[HTML][HTML] Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis

C Danwang, JJ Noubiap, A Robert… - AIDS research and therapy, 2022 - Springer
Background Data on the association of human immunodeficiency virus (HIV) infection with
adverse outcomes in patients with COVID-19 are conflicting. This systematic review and …

HIV and COVID-19: review of clinical course and outcomes

LK Barbera, KF Kamis, SE Rowan… - HIV research & …, 2021 - Taylor & Francis
Background: Understanding the relationship between HIV and SARS-CoV-2 has important
public health implications. Objective: To summarize current research on COVID-19 among …

[HTML][HTML] Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study

W Jassat, C Cohen, S Tempia, M Masha… - The Lancet …, 2021 - thelancet.com
Background The interaction between COVID-19, non-communicable diseases, and chronic
infectious diseases such as HIV and tuberculosis is unclear, particularly in low-income and …

[HTML][HTML] Global and regional prevalence and outcomes of COVID-19 in people living with HIV: a systematic review and meta-analysis

T Oyelade, JS Alqahtani, AM Hjazi, A Li… - Tropical medicine and …, 2022 - mdpi.com
Background: The relationship between HIV (human immunodeficiency virus) and COVID-19
clinical outcome is uncertain, with conflicting data and hypotheses. We aimed to assess the …

[HTML][HTML] Risk of mortality in HIV-infected COVID-19 patients: a systematic review and meta-analysis

T Dzinamarira, G Murewanhema, I Chitungo… - Journal of Infection and …, 2022 - Elsevier
Background The relationship between HIV infection and COVID-19 clinical outcomes
remains a significant public health research problem. We aimed to determine the …

Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition

T Nkosi, C Chasara, AO Papadopoulos, TL Nguni… - Elife, 2022 - elifesciences.org
In some instances, unsuppressed HIV has been associated with severe COVID-19 disease,
but the mechanisms underpinning this susceptibility are still unclear. Here, we assessed the …

[HTML][HTML] Targeted covid-19 vaccination (tav-covid) considering limited vaccination capacities—an agent-based modeling evaluation

B Jahn, G Sroczynski, M Bicher, C Rippinger… - Vaccines, 2021 - mdpi.com
(1) Background: The Austrian supply of COVID-19 vaccine is limited for now. We aim to
provide evidence-based guidance to the authorities in order to minimize COVID-19-related …

[HTML][HTML] Tenofovir, another inexpensive, well-known and widely available old drug repurposed for SARS-COV-2 infection

I Zanella, D Zizioli, F Castelli, E Quiros-Roldan - Pharmaceuticals, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is spreading
worldwide with different clinical manifestations. Age and comorbidities may explain severity …

[HTML][HTML] COVID-19 burden on HIV patients attending antiretroviral therapy in Addis Ababa, Ethiopia: a multicenter cross-sectional study

D Chilot, Y Woldeamanuel, T Manyazewal - Frontiers in medicine, 2022 - frontiersin.org
Background There has been promising progress toward screening, testing, and retaining
patients with HIV in care in Ethiopia. Concern exists that possible disruptions in HIV …

[HTML][HTML] Embracing dynamic public health policy impacts in infectious diseases responses: leveraging implementation science to improve practice

W Branch-Elliman, AR Elwy, DA Chambers - Frontiers in public health, 2023 - frontiersin.org
Rationale The host-pathogen relationship is inherently dynamic and constantly evolving.
Applying an implementation science lens to policy evaluation suggests that policy impacts …